France Influenza Drug Market to 2032
Overview
The France Influenza Drug Market is expected to reach a 291.14 USD Million by 2032 and is projected to grow at a CAGR of 6.81% from 2025 to 2032.
Revenue, 2024 (USD Million)
190.44
Forecast, 2032 (USD Million)
291.14
CAGR, 2024 - 2032
6.81%
Report Coverage
France
France Influenza Drug Market 2018-2032 USD Million
France Influenza Drug Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 190.44 USD Million
- Projected Market Size (2032): 291.14 USD Million
- CAGR (2025-2032): 6.81%
Key Findings of France Influenza Drug Market
- The France Influenza Drug Market was valued at 190.44 USD Million in 2024.
- The France Influenza Drug Market is likely to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 332.91 USD Million
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.53% during the forecast period from 2024 to 2032.
France Influenza Drug Market Scope
France Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Adults
- Pediatrics
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
France Influenza Drug Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 190.44 USD Million |
| Market Value in 2032 | 291.14 USD Million |
| CAGR (2025-2032) | 6.81% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Treatment,Route of Administration,Age,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 190.44 USD Million in 2024
- Key Country: France, leading in terms of revenue with value of 190.44 USD Million in 2024.
Segments and Scope
-
France Influenza Drug Market to 2032, By Type
- Influenza A is the largest segment in France Influenza Drug Market to 2032 with a revenue of 92.83 USD Million in the year 2024.
- Influenza A is the Fastest growing segment in France Influenza Drug Market to 2032 with a Growth rate of 7.28 % in forecast period 2025-2032.
-
France Influenza Drug Market to 2032, By Treatment
- Vaccines is the largest segment in France Influenza Drug Market to 2032 with a revenue of 332.91 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in France Influenza Drug Market to 2032 with a Growth rate of 6.83 % in forecast period 2025-2032.
-
France Influenza Drug Market to 2032, By Route of Administration
- Oral is the largest segment in France Influenza Drug Market to 2032 with a revenue of 85.74 USD Million in the year 2024.
- Oral is the Fastest growing segment in France Influenza Drug Market to 2032 with a Growth rate of 7.53 % in forecast period 2025-2032.
-
France Influenza Drug Market to 2032, By Age
- Pediatrics is the largest segment in France Influenza Drug Market to 2032 with a revenue of 98.44 USD Million in the year 2024.
- Pediatrics is the Fastest growing segment in France Influenza Drug Market to 2032 with a Growth rate of 7.23 % in forecast period 2025-2032.
-
France Influenza Drug Market to 2032, By End User
- Hospitals is the largest segment in France Influenza Drug Market to 2032 with a revenue of 139.50 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in France Influenza Drug Market to 2032 with a Growth rate of 6.97 % in forecast period 2025-2032.
-
France Influenza Drug Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in France Influenza Drug Market to 2032 with a revenue of 108.67 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in France Influenza Drug Market to 2032 with a Growth rate of 7.12 % in forecast period 2025-2032.
France Influenza Drug Market Company Share Analysis
| Company Name |
|
||
| Sanofi | |||
| AstraZeneca | |||
| GSK plc. | |||
| CSL | |||
| F. Hoffmann-La Roche Ltd. | |||
France Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million
France Influenza Drug Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Influenza Drug Market is segmented based on Segmentation Type,Treatment,Route of Administration,Age,End User,Distribution Channel.
France Influenza Drug Market was valued at USD 190.44(Revenue in USD Million) in 2022.
France Influenza Drug Market is projected to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the France Influenza Drug Market, holding a largest market share of 332.91 USD Million in 2024
France Influenza Drug Market Scope
France Influenza Drug Market Segmentation & Scope
Type
- Influenza C
- Influenza B
- Influenza A
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Adults
- Pediatrics
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The France Influenza Drug Market is segmented based on Segmentation Type,Treatment,Route of Administration,Age,End User,Distribution Channel.
France Influenza Drug Market was valued at USD 190.44(Revenue in USD Million) in 2022.
France Influenza Drug Market is projected to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
The estimated market value of the France Influenza Drug Market for final year is USD 291.14 (USD Million).
France Influenza Drug Market Company Profiling
Frequently Asked Questions
The France Influenza Drug Market is segmented based on Segmentation Type,Treatment,Route of Administration,Age,End User,Distribution Channel.
France Influenza Drug Market was valued at USD 190.44(Revenue in USD Million) in 2022.
France Influenza Drug Market is projected to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
The estimated market value of the France Influenza Drug Market for final year is USD 291.14 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.